EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

C1orf226 Promotes Glioma Stemness and Oncogenesis in Glioma via PLK 1‐Mediated Wnt/β‐Catenin Signaling

Yanbing Lu, Chao Jiang iD, Hongfei Wu, Junkui Shang, Bin Wang, Shundong Cang, Jiewen Zhang iD

Cancer Medicine · 2026-06 · 15 (6)

DOI: 10.1002/cam4.72048 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancer Medicine, online erschienen am 17.06.2026. Verfasst von Yanbing Lu und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, The People's Hospital of Zhengzhou University and Henan Provincial People's Hospital, Zhengzhou, China. Hauptthemen laut MEDLINE: Protein Serine-Threonine Kinases, Proto-Oncogene Proteins, Glioma, Cell Cycle Proteins. Die Arbeit nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Hainan Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Glioma stem cells (GSCs) are pivotal drivers of tumor progression and therapeutic resistance; however, the underlying regulatory mechanisms have not been fully elucidated. This study aimed to identify novel oncogenic drivers in glioma via a comprehensive multiomics analysis.

Methods

We integrated three datasets to screen potential oncogenic drivers. Functional experiments were performed to examine the effects of C1orf226 on glioma cell proliferation, cell cycle, epithelial–mesenchymal transition (EMT), and apoptosis. Additionally, tumor sphere formation assays, ALDH+/CD133+ cell detection, and stemness marker analysis were used to evaluate the role of C1orf226 in GSC stemness. Mechanistic studies involving immunoprecipitation (IP) and ubiquitination assays were applied to characterize the interaction between C1orf226 and PLK1, as well as their regulation on β‐catenin stability and Wnt/β‐catenin signaling. Rescue assays further verified the functional crosstalk between C1orf226 and PLK1. Xenograft mouse models were used in vivo to assess the impacts of C1orf226 knockdown on tumor growth and stemness markers.

Results

C1orf226 was significantly upregulated in glioma tissues compared with normal brain tissues. Its high expression correlated with shorter patient survival and served as an independent prognostic factor in the CGGA cohort. In vitro, C1orf226 exerted oncogenic function by facilitating cell proliferation, cell cycle progression, EMT‐like processes, and stemness, and suppressing apoptosis. Mechanistically, C1orf226 interacts with PLK1 to block its degradation, thereby activating PLK1 and downstream Wnt/β‐catenin signaling. Rescue experiments verified that PLK1 overexpression restored β‐catenin stability, Wnt/β‐catenin target gene expression, and GSC properties impaired by C1orf226 knockdown. In vivo, C1orf226 knockdown restrained xenograft growth and reduced stemness marker levels, and PLK1 co‐expression abrogated these effects.

Conclusions

Our findings reveal that C1orf226 is a PLK1‐dependent regulator of Wnt/β‐catenin signaling and GSC plasticity, highlighting its potential as a promising therapeutic target in glioma.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Protein Serine-Threonine KinasesProto-Oncogene ProteinsGliomaCell Cycle ProteinsWnt Signaling PathwayNeoplastic Stem CellsBrain NeoplasmsHumansAnimalsPolo-Like Kinase 1MiceCell Line, TumorCell ProliferationGene Expression Regulation, NeoplasticEpithelial-Mesenchymal TransitionCarcinogenesisApoptosisPrognosisFemaleMalebeta Catenin

Stichwörter der Autor:innen

C1orf226PLK1Wnt/β‐catenin signalingglioma stem cells

Substanzen

Protein Serine-Threonine KinasesProto-Oncogene ProteinsPolo-Like Kinase 1Cell Cycle Proteinsbeta Catenin

Autor:innen und Institutionen

  • Department of Neurology, The People's Hospital of Zhengzhou University and Henan Provincial People's Hospital, Zhengzhou, China.
  • Department of Neurology, Zhoukou City Central Hospital, Zhoukou, China.
  • Department of Vascular Surgery, Hainan Affiliated Hospital of Hainan Medical University and Hainan General Hospital, Haikou, China.
  • Department of Neurosurgery, The People's Hospital of Zhengzhou University and Henan Provincial People's Hospital, Zhengzhou, China.
  • Department of Oncology, The People's Hospital of Zhengzhou University and Henan Provincial People's Hospital, Zhengzhou, China.

ORCID-Profile: Chao Jiang, Jiewen Zhang

Förderung

  • National Natural Science Foundation of China
  • Natural Science Foundation of Hainan Province

Zitieren

APA

Lu, Y., Jiang, C., Wu, H., Shang, J., Wang, B., Cang, S., & Zhang, J. (2026). C1orf226 Promotes Glioma Stemness and Oncogenesis in Glioma via PLK 1‐Mediated Wnt/β‐Catenin Signaling. Cancer Medicine, 15(6). https://doi.org/10.1002/cam4.72048

Vancouver

Lu Y, Jiang C, Wu H, Shang J, Wang B, Cang S, et al. C1orf226 Promotes Glioma Stemness and Oncogenesis in Glioma via PLK 1‐Mediated Wnt/β‐Catenin Signaling. Cancer Medicine. 2026;15(6). doi:10.1002/cam4.72048

BibTeX
@article{Lu2026,
  author = {Lu, Yanbing and Jiang, Chao and Wu, Hongfei and Shang, Junkui and Wang, Bin and Cang, Shundong and Zhang, Jiewen},
  title = {C1orf226 Promotes Glioma Stemness and Oncogenesis in Glioma via PLK 1‐Mediated Wnt/β‐Catenin Signaling},
  journal = {Cancer Medicine},
  year = {2026},
  volume = {15},
  number = {6},
  doi = {10.1002/cam4.72048}
}
Kostenlos starten →